Press Releases

Language
Boule Diagnostics AB har idag publicerat den fullständiga årsredovisningen för räkenskapsåret 2021 på www.boule.com. Den svenska årsredovisningen i sin helhet återfinns nedan som PDF och i European Single Electronic Format (ESEF), en tryckt version...
Aktieägarna i Boule Diagnostics AB, org.nr 556535-0252 ("Bolaget"), kallas härmed till årsstämma torsdagen den 5 maj 2022 kl. 18.00 på Domnarvsgatan 4, Spånga. Inpassering sker från kl. 17.30.
Aktieägarna i Boule Diagnostics AB, org.nr 556535-0252 (”Bolaget”), kallas härmed till årsstämma torsdagen den 5 maj 2022 kl. 18.00 på Domnarvsgatan 4, Spånga. Inpassering sker från kl. 17.30. Med anledning av Covid-19 pandemin har styrelsen...
Valberedningen i Boule Diagnostics AB föreslår årsstämman 2022 att styrelsen ska bestå av fem styrelseledamöter inklusive styrelseordförande. Valberedningen föreslår att årsstämman nyväljer Yvonne Mårtensson till styrelsens ordförande samt...
Valberedningen i Boule Diagnostics AB föreslår årsstämman 2022 att styrelsen ska bestå av fem styrelseledamöter inklusive styrelseordförande. Valberedningen föreslår att årsstämman nyväljer Yvonne Mårtensson till styrelsens ordförande samt...
2022-02-03 08:30
Boule Diagnostics AB: Boule Diagnostics (publ) bokslutskommuniké januari-december 2021
Regulatory
Rekordkvartal avslutade året Kvartalet oktober–december 2021 Helåret januari–december 2021 VD Jesper Söderqvist kommenterar
Rekordförsäljning i kvartalet och bra vinsttillväxt
Omsättningen för fjärde kvartalet 2021 var 140 MSEK, vilket...
2022-01-26 15:00
Boule Diagnostics AB: Boule Diagnostics - Inbjudan till presentation av bokslutskommuniké 2021
Boule Diagnostics AB offentliggör bokslutskommunikén för perioden januari-december 2021 torsdagen den 3 februari 2022 klockan 08:30. Efter offentliggörandet av bokslutskommunikén håller Boule klockan 09:00 ett Teams Live Event för press och aktiemarknad...
Boule Diagnostics AB offentliggör bokslutskommunikén för perioden januari–december 2021 torsdagen den 3 februari 2022 klockan 08:30. Efter offentliggörandet av bokslutskommunikén håller Boule klockan 09:00 ett Teams Live Event för press och aktiemarknad...
Boule Diagnostics AB utser Annette Colin till ny CFO med tillträde den 4:e april 2022. Annette Colin har mer än 25 års erfarenhet från ledande befattningar som VD, CFO, COO och koncernredovisningschef inklusive mer än 15 år inom Life Science. Annette...
2021-12-09 16:30
Boule Diagnostics AB: CFO Christina Rubenhag kommer lämna Boule i juni 2022
Regulatory
Boule Diagnostics AB:s CFO Christina Rubenhag har beslutat att lämna sin tjänst för att tillträda som CFO i AddLife. Christina har haft sin roll sedan 2017 och kommer fortsätta i denna under hennes uppsägningstid om sex månader för att säkerställa...
2021-11-10 08:30
Boule Diagnostics AB: Boule Diagnostics (publ) delårsrapport juli-september 2021
Regulatory
Fortsatt tillväxt för alla produkter Kvartalet juli–september 2021 VD Jesper Söderqvist kommenterar
Fortsatt återhämtning och välfylld orderbok
Vi har sett en fortsatt återhämtning i marknaden, och under tredje kvartalet fortsatte den positiva...
2021-11-02 15:00
Boule Diagnostics AB: Boule Diagnostics - Inbjudan till presentation av delårsrapport Q3 2021
Boule Diagnostics AB offentliggör delårsrapporten för perioden januari-september 2021 onsdagen den 10 november 2021 klockan 08:30. Efter offentliggörandet av delårsrapporten håller Boule klockan 09:00 ett Teams Live Event för press och aktiemarknad...
Boule Diagnostics AB offentliggör delårsrapporten för perioden januari–september 2021 onsdagen den 10 november 2021 klockan 08:30. Efter offentliggörandet av delårsrapporten håller Boule klockan 09:00 ett Teams Live Event för press och aktiemarknad...
Årsstämman 2021 i Boule Diagnostics AB (publ), ("Boule"), beslutade att en valberedning baserad på ägarförhållandena den 30 september 2021 ska utses för att föreslå årsstämman 2022:
2021-10-22 15:00
Boule Diagnostics – Valberedning inför årsstämman 2022
Årsstämman 2021 i Boule Diagnostics AB (publ), (”Boule”), beslutade att en valberedning baserad på ägarförhållandena den 30 september 2021 ska utses för att föreslå årsstämman 2022: Boules största aktieägare vid ovanstående tidpunkt...
2021-07-19 08:30
Boule Diagnostics AB: Boule Diagnostics (publ) delårsrapport april-juni 2021
Regulatory
Kraftigt förbättrad instrumentförsäljning
The Annual General Meeting (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance sheet for 2017. Furthermore, it was decided that a dividend of SEK 2.00 per share will be distributed...
Continued improvements of profitability in spite of slower sales at the start of the year Strengthened Executive Team Kiarash Farr has been appointed SVP of Commercial Operations. He succeeds Claes Blanche who has communicated that he wants to phase...
2018-05-09 11:01
Boule Diagnostics – Q1 2018 presentation
Boule Diagnostics AB will publish the interim report for the period January – March 2018 at 15:00, Monday, 14 May. Following the publication, Boule will hold a conference call for media and investors. CEO Fredrik Dalborg and CFO Christina Rubenhag presents...
Boule Diagnostics AB has published the full annual report for the fiscal year 2017 at www.boule.com. The annual report is available in Swedish below. The annual report will also be made available in English at www.boule.com in time for the Annual General...
2018-04-19 15:31
Boule Diagnostics AB (publ) acquires technologies for the next generation product platform
Regulatory
Boule has acquired technologies that will be used for the next generation platform for the 5-part segment Through this acquisition Boule will get access to new technologies in the field of laser optics that will be adapted to Boule’s requirements and...
Continued growth, increased profitability and strong cash flow Strengthened distribution network At year-end, Boule choose to terminate the distribution agreement the company had with the nationwide distributor of Swelab in India. The company will instead...
2018-02-15 10:31
Boule Diagnostics – Q4 2017 presentation
Boule Diagnostics AB will publish the year-end report for the period January – December 2017 at 14:30, Friday, 16 February. In connection to the release, Boule will hold a conference call for media and investors. CEO Fredrik Dalborg and CFO Christina...
The incentive programs for senior management and key individuals implemented during 2013 and 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of 2017. In total, the incentive...
Kiarash Farr has been appointed Senior Vice President Commercial Operations of Boule Diagnostics and member of the Group Management Team. He succeeds Claes Blanche who has communicated that he wants to phase out of his current role and take a part time...
The incentive programs for senior management and key individuals implemented during 2013 and 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of 2017. In total, the incentive...
The Annual General Meeting, (”AGM”), 2017 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership structure as per September 30, 2017, will be appointed to propose for the AGM of 2018 the following...
Strong quarter with good margins Strategic agreements to strengthen and expand the product portfolio In quarter four 2017, Boule will commence sales and distribution of a CRP product from Orion Diagnostica Oy via Boule’s own sales organization in...
2017-11-07 19:50
Boule Diagnostics – Q3 2017 presentation
Boule Diagnostics AB will publish their interim report for the period January – September 2017 at 08:45, Wednesday, 8 November. In connection to the release, Boule will hold a webinar including a presentation and conference call for media and investors...
The incentive program for senior management and key individuals implemented at the Annual General Meeting held on May 13, 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of...
The incentive program for senior management and key individuals implemented at the Annual General Meeting held on May 13, 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of...
Christina Rubenhag has been appointed Chief Financial Officer (CFO) of Boule Diagnostics and member of the Group Management Team. She succeeds Fredrik Alpsten who, as communicated earlier, will leave Boule to assume a position at another company. Christina...
The incentive program for senior management and key individuals implemented at the Annual General Meeting held on May 13, 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of...
Stable sales following a strong first quarter, restructuring expenses burden profitability Actions to increase efficiency and profitability During the quarter, the company has completed several processes to increase efficiency and future profitability...
2017-08-23 11:16
Boule Diagnostics changes the publication date of interim report January - June 2017
Boule Diagnostics AB has decided to publish the interim report for the first six months of 2017 earlier than previously announced. The new publishing date is Friday, August 25 at 08:45. For further information, please contact: Fredrik Dalborg, CEO and...
The incentive program for senior management and key individuals implemented at the Annual General Meeting held on May 13, 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of...